Better Edge : A Northwestern Medicine podcast for physicians
Better Edge : A Northwestern Medicine podcast for physicians
Predicting Which Bladder Cancer Patients Will Respond to Immunotherapy
Loading
/
  • LISTEN ON:
  • Listen on Spotify
  • Listen on iHeart
  • Listen on Apple Podcasts
  • Listen on Google Podcasts
  • Listen on TuneIn
  • Listen on Stitcher
Placeholder Ad
Placeholder Ad
Placeholder Ad
Placeholder Ad

Predicting Which Bladder Cancer Patients Will Respond to Immunotherapy

predicting-which-bladder-cancer-patients-will-respond-to-immunotherapyNorthwestern Medicine scientists, led by Joshua J. Meeks, MD, PhD, have developed a biomarker signature test to predict which patients with bladder cancer will respond to immunotherapy. The discovery, from a new study published in Nature Communications, could improve the survival of bladder cancer patients. Dr. Meeks joins this episode of the Better Edge podcast to discuss the results.

Pericardial Disease: Its Prevalence and the Role of Multidisciplinary Care

Northwestern Medicine scientists, led by Joshua J. Meeks, MD, PhD, have developed a biomarker signature test to predict which patients ...

Listen

Northwestern Medicine Geriatrics Home Care Program

Northwestern Medicine scientists, led by Joshua J. Meeks, MD, PhD, have developed a biomarker signature test to predict which patients ...

Listen

Continuity Matters: Transitioning Pediatric Patients to Adult Specialists

Northwestern Medicine scientists, led by Joshua J. Meeks, MD, PhD, have developed a biomarker signature test to predict which patients ...

Listen

The Connection Between Diabetes and Heart Disease

Northwestern Medicine scientists, led by Joshua J. Meeks, MD, PhD, have developed a biomarker signature test to predict which patients ...

Listen

Socioeconomic Status and Readmission After Acute Type A Aortic Dissection Repair

Northwestern Medicine scientists, led by Joshua J. Meeks, MD, PhD, have developed a biomarker signature test to predict which patients ...

Listen

Highlights from AAN 2024

Northwestern Medicine scientists, led by Joshua J. Meeks, MD, PhD, have developed a biomarker signature test to predict which patients ...

Listen

From Brain to Liver: Advances in Wilson Disease Management

Northwestern Medicine scientists, led by Joshua J. Meeks, MD, PhD, have developed a biomarker signature test to predict which patients ...

Listen

Seizure Solutions: Inside the Northwestern Medicine First Seizure Clinic

Northwestern Medicine scientists, led by Joshua J. Meeks, MD, PhD, have developed a biomarker signature test to predict which patients ...

Listen

First Seizure Clinic

Northwestern Medicine scientists, led by Joshua J. Meeks, MD, PhD, have developed a biomarker signature test to predict which patients ...

Listen

Advancing LGBTQ+ Diversity, Equity and Inclusion in Ophthalmology

Northwestern Medicine scientists, led by Joshua J. Meeks, MD, PhD, have developed a biomarker signature test to predict which patients ...

Listen